GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 386 filers reported holding GLOBUS MED INC in Q1 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $178,740 | -16.6% | 3,600 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $214,344 | -22.8% | 3,600 | -26.5% | 0.00% | -20.0% |
| Q1 2023 | $277,536 | -23.7% | 4,900 | 0.0% | 0.01% | -28.6% |
| Q4 2022 | $363,923 | +24.6% | 4,900 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $292,000 | +6.2% | 4,900 | 0.0% | 0.01% | +16.7% |
| Q2 2022 | $275,000 | -24.0% | 4,900 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $362,000 | +2.3% | 4,900 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $354,000 | -13.7% | 4,900 | -8.4% | 0.01% | -12.5% |
| Q3 2021 | $410,000 | -1.2% | 5,352 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $415,000 | +37.4% | 5,352 | +9.2% | 0.01% | +14.3% |
| Q1 2021 | $302,000 | -5.6% | 4,900 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $320,000 | +31.7% | 4,900 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $243,000 | +3.8% | 4,900 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $234,000 | +12.5% | 4,900 | 0.0% | 0.01% | -14.3% |
| Q1 2020 | $208,000 | -28.0% | 4,900 | 0.0% | 0.01% | -12.5% |
| Q4 2019 | $289,000 | – | 4,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |